Dr Reddy’s Laboratories share price at ₹1,150.10 on September 8; price up 0.52%
Last Updated: 8th September 2026 - 06:38 pm
Key Takeaways
- Dr Reddy’s Laboratories stood at ₹1,150.10 in the latest September 8 reading, up 0.52%, with only ₹10 separating the stated high and low.
- The share remained below the 50-day, 100-day and 200-day moving averages, with the widest gap to the 200-day DMA.
- Returns were negative across every listed period, ranging from -1.87% over one month to -11.79% over six months.
Dr Reddy’s Laboratories was at ₹1,150.10 in the latest September 8 reading on its individual page. The previous close stood at ₹1,144, and the stated gain was ₹5.90, or 0.52%. The stock opened at ₹1,147, leaving the latest price ₹3.10 above the session’s starting level.
The stated intraday band was narrow. Dr Reddy’s traded between ₹1,144 and ₹1,154. That left only ₹10 from low to high. The latest figure was ₹6.10 above the low and ₹3.90 below the high. The opening price sat three rupees above the low.
Its moving averages were all higher than the latest price. The 50-day DMA stood at ₹1,199.90, leaving a ₹49.80 gap. The 100-day average was ₹1,226.70. The 200-day DMA came to ₹1,242.80, which was ₹92.70 above the September 8 figure. From the 50-day to the 200-day average, the difference was ₹42.90.
Trading volume reached 383,222 shares. Market capitalisation stood at ₹95,996 crore. The stock’s 52-week low was ₹1,101 and the high ₹1,415. At ₹1,150.10, Dr Reddy’s was only ₹49.10 above the annual low. The distance to the high was much larger at ₹264.90.
Return figures were negative across every period shown. One month stood at -1.87%. Three months was -10.02%, while six months was -11.79%. The one-year return came to -9.31%. The six-month figure was the lowest of the four.
Frequently Asked Questions
What was Dr Reddy’s Laboratories’ September 8 trading range?
How far was Dr Reddy’s from its moving averages?
What returns did Dr Reddy’s Laboratories record?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
01
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.